Some proteins in the human body are easy to block with a drug; they have an obvious spot in their structure where a drug can ...

Primary target patient population for the CBX-12 Phase 2 study is women with platinum-resistant or refractory ovarian cancer ...

STOCKHOLM - Cancer research or drugs treating cardiovascular illnesses could win a Nobel Prize on Oct 7 when a week of ...

Summit Therapeutics Inc. may have a potential successor to Merck's Keytruda with strong clinical data from China, but awaits ...

GlobalData’s report assesses the drugs in the Cathepsin L1 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Apr. 10, 2024 — New research sheds light on the significance of the glucocorticoid receptor in drug-resistant prostate cancer, showing that the development of drug resistance could be prevented ...

Healthcare drug developers have found that AI machine learning models have cut their discovery process down by 70% to 80%.

A new drug combo recently approved by the Food & Drug Administration can halt lung cancer in its treacherous tracks — for ...

Prolactin is an important hormone in reproduction, pregnancy and childbirth. But could it also play a role in the development ...

AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune ...

Cancer death rates have fallen by 25% since the turn of the century. Stage 4 cancer diagnoses — previously considered death ...